Laouedj et al. reported that AML patients displayed significantly higher levels of S100A8 in plasma levels, and using a mouse model of AML, they argue that this secretion came from leukemic cells and not microenvironment [32]. This evidence concerns the gene S100A8 and acute myeloid leukemia.